Clinical trial / 2015
Vitamin C added to citalopram did not improve major depressive disorder symptoms.
An 8-week randomized double-blind placebo-controlled trial evaluated 43 adult patients with major depressive disorder receiving citalopram with either vitamin C (n=21) or placebo (n=22). Although depression scores declined in both arms, the difference between groups was not statistically significant (P = .5). Remission rates, response rates, and adverse effects showed no significant differences between the vitamin C and placebo groups.
- Study type
- Randomized controlled trial
- Who was studied
- 43 adults with major depressive disorder
- What was measured
- Depressive symptoms measured by Hamilton Depression Rating Scale
THE PAPER
Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial.
Sahraian A, Ghanizadeh A, Kazemeini F. Trials, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.